Seeing Is Believing
Healthcare - Sector
BGNE is currently covered by 2 analysts with an average price target of $241.37. This is a potential upside of $56.66 (30.68%) from yesterday's end of day stock price of $184.71.
BeiGene Ltd's activity chart (see below) currently has 99 price targets and 77 ratings on display. The stock rating distribution of BGNE is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 69.41% with an average time for these price targets to be met of 165.2 days.
Highest price target for BGNE is $260, Lowest price target is $260, average price target is $260.
Most recent stock forecast was given by YARON WERBER from TD COWEN on 12-Nov-2024. First documented stock forecast 28-Feb-2016.
Currently out of the existing stock ratings of BGNE, 1 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$260
$75.29 (40.76%)
$254
11 months 11 days ago
(12-Nov-2024)
5/9 (55.56%)
$64.55 (33.03%)
150
Buy
$288
$103.29 (55.92%)
$285
1 years 2 months 16 days ago
(07-Aug-2024)
0/4 (0%)
$104.97 (57.35%)
Hold
$152.5
$-32.21 (-17.44%)
$164.3
1 years 3 months 15 days ago
(08-Jul-2024)
4/4 (100%)
$7.97 (5.51%)
103
Buy
$345
$160.29 (86.78%)
$350
1 years 7 months 27 days ago
(26-Feb-2024)
2/5 (40%)
$165.31 (92.00%)
350
Buy
$319
$134.29 (72.70%)
$321
2 years 1 months 25 days ago
(28-Aug-2023)
4/10 (40%)
$105.41 (49.35%)
105
What is BGNE (BeiGene Ltd) average time for price targets to be met?
Which analyst has the current highest performing score on BGNE (BeiGene Ltd) with a proven track record?
Which analyst has the most public recommendations on BGNE (BeiGene Ltd)?
Which analyst is the currently most bullish on BGNE (BeiGene Ltd)?
Which analyst is the currently most reserved on BGNE (BeiGene Ltd)?